ArticleInternational journal of cardiology. Congenital heart disease2024

Safety of SGLT-2 inhibitors in the management of heart failure in the adult congenital heart disease patient population.

Ahmed Kheiwa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.